|
ADGC case-control summary statistics on 7050 samples not included in the IGAP-2013 discovery stage- Hu et al. (2019) |
|
|
|
|
CSF TREM2 Summary Statistics |
|
|
|
|
eGWAS Mayo |
|
|
|
|
IGAP Summary Statistics- Lambert et al. (2013) |
|
|
|
|
Results of gene-based weighted burden analyses using SCOREASSOC and GENEVARASSOC applied to the ADSP discovery sample |
|
|
|
|
Prediction of Psychosis in Alzheimer Disease Summary Statistics - DeMichele-Sweet, et. al. 2021 |
|
|
|
|
ADSP Discovery Case/Control Association Results |
|
|
|
|
A fast and robust strategy to remove variant level artifacts in Alzheimer’s Disease Sequencing Project data (Belloy et al. 2022) (via DSS) |
|
|
|
|
ADGC Summary Statistics- Naj et al. (2011) |
|
|
|
|
Results of gene - based weighted burden analyses using SCOREASSOC and GENEVARASSOC and multivariate analyses of variants near APOE applied to the ADSP Discovery Case - Control Based Extension Study. |
|
|
|
|
ADGC African American Summary Statistics- Reitz et al. (2013) |
|
|
|
|
CLU, A potential endophenotype for AD: Summary Statistics- Deming et al. (2016) |
|
|
|
|
Novel risk loci and pathways associated with Alzheimer disease in African Americans: A GWAS and meta-analysis summary statistics- Kunkle et al. (2020) |
|
|
|
|
Multi-Ethnic Exome Array Study of AD, FTD, and PSP |
|
|
|
|
IGAP APOE-Stratified Analysis Summary Statistics- Jun et al. (2015) |
|
|
|
|
IGAP Summary Statistics, ADGC subset- Lambert et al. (2013) |
|
|
|
|
ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) |
|
|
|
|
UAB/HudsonAlpha Families with Neurodegenerative Diseases |
|
|
|
|
CSF Aβ/ptau Summary Statistics - Deming Y et al. (2017) |
|
|
|
|
The Prediction of Alzheimer’s Disease through Multi-Trait Genetic Modeling (via DSS) |
|
|
|
